1. Home
  2. Clinical Topics
  3. FDA to host meeting on the development of products for rare diseases
Clinical TopicsDrugs and DevicesHealthcare & TechnologyNewsPublic HealthRare Diseases

FDA to host meeting on the development of products for rare diseases

Share
By: Lydia L. Kim, Digital Content Editor

On February 24, the U.S. Food and Drug Administration (FDA) is hosting a public meeting to celebrate FDA Rare Disease Day 2020 which will focus on what the future holds for the product development process for rare diseases.

Part of the FDA’s mission is the focus on increasing the quality of life of patients and their family members, which is an especially important area for those whose lives are affected by a rare disease.

The meeting on February 24 will allow the FDA to hear directly from stakeholders in various rare disease communities, including, patients, caregivers, clinicians, and researchers.

American Nurse applauds the FDA’s efforts in this area, and our team is excited to see the outcome of the meeting.Learn more about the FDA’s initiatives in the rare disease space here.

Source:
https://www.fda.gov/news-events/fda-voices-perspectives-fda-leadership-and-experts/fda-harnesses-technology-and-collaboration-support-rare-disease-product-development?utm_campaign=FDA%20Voices%20on%20Medical%20Products%3A%201%2F21%2F2020&utm_medium=email&utm_source=Eloqua

 

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts